67 related articles for article (PubMed ID: 8918924)
1. Rates of shutdown of HIV-1 into latency: roles of the LTR and tat/rev/vpu gene region.
Song SK; Li H; Cloyd MW
Virology; 1996 Nov; 225(2):377-86. PubMed ID: 8918924
[TBL] [Abstract][Full Text] [Related]
2. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
Li XD; Moore B; Cloyd MW
Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
4. Interferon inhibits the replication of HIV-1, SIV, and SHIV chimeric viruses by distinct mechanisms.
Korth MJ; Taylor MD; Katze MG
Virology; 1998 Aug; 247(2):265-73. PubMed ID: 9705919
[TBL] [Abstract][Full Text] [Related]
5. 5' long terminal repeat (LTR)-selective methylation of latently infected HIV-1 provirus that is demethylated by reactivation signals.
Ishida T; Hamano A; Koiwa T; Watanabe T
Retrovirology; 2006 Oct; 3():69. PubMed ID: 17034647
[TBL] [Abstract][Full Text] [Related]
6. Chronology of genetic changes in the vpu, env, and Nef genes of chimeric simian-human immunodeficiency virus (strain HXB2) during acquisition of virulence for pig-tailed macaques.
McCormick-Davis C; Zhao LJ; Mukherjee S; Leung K; Sheffer D; Joag SV; Narayan O; Stephens EB
Virology; 1998 Sep; 248(2):275-83. PubMed ID: 9721236
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of HIV-1 replication and reactivation from latency by tat transdominant negative mutants in the cysteine rich region.
Caputo A; Grossi MP; Bozzini R; Rossi C; Betti M; Marconi PC; Barbanti-Brodano G; Balboni PG
Gene Ther; 1996 Mar; 3(3):235-45. PubMed ID: 8646555
[TBL] [Abstract][Full Text] [Related]
8. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation.
Williams SA; Chen LF; Kwon H; Ruiz-Jarabo CM; Verdin E; Greene WC
EMBO J; 2006 Jan; 25(1):139-49. PubMed ID: 16319923
[TBL] [Abstract][Full Text] [Related]
9. StpC-based gene therapy targeting latent reservoirs of HIV-1.
Turner LS; Tsygankov AY; Henderson EE
Antiviral Res; 2006 Dec; 72(3):233-41. PubMed ID: 16891001
[TBL] [Abstract][Full Text] [Related]
10. Changes in the host range and growth potential of an HIV-1 clone are conferred by the vpu gene.
Du B; Wolf A; Lee S; Terwilliger E
Virology; 1993 Jul; 195(1):260-4. PubMed ID: 8317102
[TBL] [Abstract][Full Text] [Related]
11. Molecular biology of human immunodeficiency virus type 1.
Wang WK; Chen MY; Chuang CY; Jeang KT; Huang LM
J Microbiol Immunol Infect; 2000 Sep; 33(3):131-40. PubMed ID: 11045374
[TBL] [Abstract][Full Text] [Related]
12. Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques.
Hout DR; Gomez ML; Pacyniak E; Mulcahy ER; Gomez LM; Jackson M; Flick M; Fegley B; McCormick C; Wisdom BJ; Culley N; Pinson DM; Powers M; Wong SW; Stephens EB
Virology; 2004 May; 323(1):91-107. PubMed ID: 15165822
[TBL] [Abstract][Full Text] [Related]
13. Derivation of infectious HIV-1 molecular clones with LTR mutations: sensitivity to the CD8+ cell noncytotoxic anti-HIV response.
Bonneau KR; Ng S; Foster H; Choi KB; Berkhout B; Rabson A; Mackewicz CE; Levy JA
Virology; 2008 Mar; 373(1):30-8. PubMed ID: 18086484
[TBL] [Abstract][Full Text] [Related]
14. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products.
Fong SE; Greenwood JD; Williamson JC; Derse D; Pallansch LA; Copeland T; Rasmussen L; Mentzer A; Nagashima K; Tobin G; Gonda MA
Virology; 1997 Jul; 233(2):339-57. PubMed ID: 9217057
[TBL] [Abstract][Full Text] [Related]
15. Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter.
Lusic M; Marcello A; Cereseto A; Giacca M
EMBO J; 2003 Dec; 22(24):6550-61. PubMed ID: 14657027
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator.
Roof P; Ricci M; Genin P; Montano MA; Essex M; Wainberg MA; Gatignol A; Hiscott J
Virology; 2002 Apr; 296(1):77-83. PubMed ID: 12036319
[TBL] [Abstract][Full Text] [Related]
17. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
[TBL] [Abstract][Full Text] [Related]
18. High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS.
Plavec I; Agarwal M; Ho KE; Pineda M; Auten J; Baker J; Matsuzaki H; Escaich S; Bonyhadi M; Böhnlein E
Gene Ther; 1997 Feb; 4(2):128-39. PubMed ID: 9081703
[TBL] [Abstract][Full Text] [Related]
19. Inducible gene expression of the human immunodeficiency virus LTR in a replication-incompetent herpes simplex virus vector.
Warden MP; Weir JP
Virology; 1996 Dec; 226(1):127-31. PubMed ID: 8941330
[TBL] [Abstract][Full Text] [Related]
20. The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication.
Accolla RS; Mazza S; De Lerma Barbaro A; De Maria A; Tosi G
Eur J Immunol; 2002 Oct; 32(10):2783-91. PubMed ID: 12355430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
